Focusing on those with the highest risk of vision problems — as well as sensitivity to costs — could help improve eye care decisions for people over 50,
To combat growing eye problems and treatment disparities in communities of color, a U-M effort works to foster a more diverse group of eye care providers.
Immunotherapy cancer drugs can cause a potentially vision-robbing side effect. In a new report, Michigan Medicine experts discuss the risks and what oncologists should know.
Medication for diabetic eye disease is crucial, but it’s hard to tell in advance when and how often patients might need it. New research aims to provide insight.
Ocular surgeries are steadily shifting away from hospitals, a move that offers convenience and financial perks. But questions of safety and accessibility remain.